أعرض في EDS

Pharmacological and non-pharmacological countermeasures to Space Motion Sickness: a systematic review.

التفاصيل البيبلوغرافية
العنوان: Pharmacological and non-pharmacological countermeasures to Space Motion Sickness: a systematic review.
المؤلفون: Khalid A; Leicester Medical School, University of Leicester, Leicester, United Kingdom., Prusty PP; Department of Audio-Vestibular Sciences, Institute of Health Sciences, Bhubaneswar, India., Arshad I; Department of Psychology, Royal Holloway University of London, Egham, United Kingdom., Gustafson HE; Department of Health and Human Performance, University of Houston, Houston, TX, United States., Jalaly I; University College London Medical School, London, United Kingdom., Nockels K; Library and Learning Services, University of Leicester, Leicester, United Kingdom., Bentley BL; Cardiff School of Technologies, Cardiff Metropolitan University, Cardiff, United Kingdom., Goel R; San Jose State University-NASA Ames Research Center, Moffett Field, CA, United States., Ferrè ER; Department of Psychological Sciences, Birkbeck University of London, London, United Kingdom.
المصدر: Frontiers in neural circuits [Front Neural Circuits] 2023 Jun 16; Vol. 17, pp. 1150233. Date of Electronic Publication: 2023 Jun 16 (Print Publication: 2023).
نوع المنشور: Systematic Review
اللغة: English
بيانات الدورية: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477940 Publication Model: eCollection Cited Medium: Internet ISSN: 1662-5110 (Electronic) Linking ISSN: 16625110 NLM ISO Abbreviation: Front Neural Circuits Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Lausanne, Switzerland] : Frontiers Research Foundation, c2007-
مواضيع طبية MeSH: Space Flight* , Vestibule, Labyrinth* , Weightlessness*, Humans ; Randomized Controlled Trials as Topic ; Space Motion Sickness/etiology ; Space Motion Sickness/prevention & control
مستخلص: Introduction: Space Motion Sickness (SMS) is a syndrome that affects around 70% of astronauts and includes symptoms of nausea, dizziness, fatigue, vertigo, headaches, vomiting, and cold sweating. Consequences range from discomfort to severe sensorimotor and cognitive incapacitation, which might cause potential problems for mission-critical tasks and astronauts and cosmonauts' well-being. Both pharmacological and non-pharmacological countermeasures have been proposed to mitigate SMS. However, their effectiveness has not been systematically evaluated. Here we present the first systematic review of published peer-reviewed research on the effectiveness of pharmacological and non-pharmacological countermeasures to SMS.
Methods: We performed a double-blind title and abstract screening using the online Rayyan collaboration tool for systematic reviews, followed by a full-text screening. Eventually, only 23 peer-reviewed studies underwent data extraction.
Results: Both pharmacological and non-pharmacological countermeasures can help mitigate SMS symptoms.
Discussion: No definitive recommendation can be given regarding the superiority of any particular countermeasure approach. Importantly, there is considerable heterogeneity in the published research methods, lack of a standardized assessment approach, and small sample sizes. To allow for consistent comparisons between SMS countermeasures in the future, standardized testing protocols for spaceflight and ground-based analogs are needed. We believe that the data should be made openly available, given the uniqueness of the environment in which it is collected.
Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021244131.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2023 Khalid, Prusty, Arshad, Gustafson, Jalaly, Nockels, Bentley, Goel and Ferrè.)
References: Front Physiol. 2017 Nov 07;8:893. (PMID: 29163225)
J Sleep Res. 1997 Mar;6(1):1-8. (PMID: 9125693)
Auton Neurosci. 2006 Oct 30;129(1-2):77-9. (PMID: 16935570)
Aviat Space Environ Med. 2005 Apr;76(4):352-6. (PMID: 15828634)
Neurol India. 2019 May-Jun;67(Supplement):S214-S218. (PMID: 31134912)
Aviat Space Environ Med. 1979 Feb;50(2):171-6. (PMID: 36067)
Radiat Prot Dosimetry. 2005;115(1-4):44-50. (PMID: 16381680)
Aviat Space Environ Med. 2005 Jul;76(7):642-6. (PMID: 16018346)
J Neurophysiol. 2005 Aug;94(2):1346-57. (PMID: 15817649)
Acta Astronaut. 1981 Sep-Oct;8(9-10):1015-8. (PMID: 11543090)
Otol Neurotol. 2004 Sep;25(5):740-5. (PMID: 15354005)
J Womens Health (Larchmt). 2014 Nov;23(11):959-62. (PMID: 25401941)
Aerosp Med Hum Perform. 2017 Jan 1;88(1):3-9. (PMID: 28061915)
Audiol Neurootol. 2012;17(4):235-42. (PMID: 22517315)
Acta Astronaut. 1994 Dec;32(12):841-3. (PMID: 11540596)
Aviat Space Environ Med. 1983 May;54(5):402-9. (PMID: 6870733)
J Clin Pharmacol. 1994 Jun;34(6):644-8. (PMID: 8083396)
Aviat Space Environ Med. 2006 Jan;77(1):2-7. (PMID: 16422446)
Aviat Space Environ Med. 2000 Oct;71(10):1013-22. (PMID: 11051308)
J Clin Pharmacol. 2000 Oct;40(10):1154-65. (PMID: 11028255)
Acta Astronaut. 1993 Aug;29(8):587-91. (PMID: 11541638)
Life Sci Space Res. 1976;14:109-18. (PMID: 11977268)
Exp Brain Res. 1986;64(2):316-34. (PMID: 3803476)
BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
J Clin Pharmacol. 1994 Jun;34(6):618-27. (PMID: 8083393)
J Appl Physiol (1985). 2015 Aug 1;119(3):213-8. (PMID: 25953832)
Aviat Space Environ Med. 2005 Oct;76(10):970-3. (PMID: 16235881)
Acta Astronaut. 1982 Jun-Jul;9(6-7):375-83. (PMID: 11541691)
Aviat Space Environ Med. 1992 Jan;63(1):46-51. (PMID: 1550533)
Aviat Space Environ Med. 1993 Mar;64(3 Pt 1):230-3. (PMID: 8447805)
NPJ Microgravity. 2017 Jan 10;3:2. (PMID: 28649624)
Front Hum Neurosci. 2017 Apr 28;11:203. (PMID: 28503140)
J Vestib Res. 2013;23(4-5):203-9. (PMID: 24284600)
J Clin Pharmacol. 1993 Nov;33(11):1092-103. (PMID: 8300892)
Aviat Space Environ Med. 2007 Aug;78(8):764-9. (PMID: 17760283)
PLoS One. 2014 Nov 19;9(11):e112131. (PMID: 25409443)
Aviat Space Environ Med. 2014 Jun;85(6):638-44. (PMID: 24919385)
Laryngoscope. 1994 Aug;104(8 Pt 1):935-9. (PMID: 8052077)
Aviat Space Environ Med. 1983 May;54(5):464-5. (PMID: 6870740)
Aviat Space Environ Med. 2001 Jan;72(1):13-20. (PMID: 11194988)
فهرسة مساهمة: Keywords: Space Motion Sickness (SMS); aerospace medicine; human space flight; non-pharmacological countermeasures; pharmacological countermeasures
تواريخ الأحداث: Date Created: 20230703 Date Completed: 20230809 Latest Revision: 20230809
رمز التحديث: 20230809
مُعرف محوري في PubMed: PMC10311550
DOI: 10.3389/fncir.2023.1150233
PMID: 37396400
قاعدة البيانات: MEDLINE
الوصف
تدمد:1662-5110
DOI:10.3389/fncir.2023.1150233